论文部分内容阅读
目的:观察新生儿颅内出血的临床治疗方法与效果。方法:选取我院2011年2月-2013年11月接诊的新生儿颅内出血患儿82例作为研究对象,根据患儿家属自愿原则分为研究组与对照组,其中研究组42例,采用苯巴比妥治疗,对照组40例,采用其他抗惊厥药物治疗,两组患者皆给予>6个月跟踪随访,对比分析两组患者NBNA(新生儿神经行为)评分与随访疗效。结果:相较于治疗前,两组患儿治疗后NBNA评分皆有明显升高,组内对比差异有统计学意义(P<0.05),但研究组治疗后NBNA评分升高更为明显,组间对比差异有统计学意义(P<0.05);随访进行疗效评价可知,研究组治愈率为95.24%(40/42),对照组治愈率为82.50%(33/40),组间对比差异有统计学意义(P<0.05)。结论:苯巴比妥治疗新生儿颅内出血可以取得比较良好的效果。转归与预后效果良好,值得借鉴。
Objective: To observe the clinical treatment of neonatal intracranial hemorrhage and results. Methods: Totally 82 neonates with intracranial hemorrhage admitted from February 2011 to November 2013 in our hospital were selected as study subjects and divided into study group and control group according to the principle of voluntary dependency of their children. The study group included 42 cases Phenobarbital treatment, the control group of 40 cases, the use of other anticonvulsant drugs, both groups were given> 6 months follow-up, comparative analysis of two groups of patients NBNA (Neonatal Neurobehavioral) score and follow-up effect. Results: Compared with before treatment, NBNA scores in both groups were significantly increased after treatment, the difference was statistically significant (P <0.05), but NBNA score increased more significantly in the study group after treatment The difference between the two groups was statistically significant (P <0.05). Follow-up evaluation showed that the cure rate was 95.24% (40/42) in the study group and 82.50% (33/40) in the control group Statistical significance (P <0.05). Conclusion: Phenobarbital can treat neonatal intracranial hemorrhage with good results. Prognosis and prognosis is good, it is worth learning.